Headquartered in Madison, WI·Fiscal year ends June·NASDAQ: ARAY·accuray.com
About Accuray
Accuray Incorporated develops, manufactures, sells and services radiation therapy systems for oncology, neuro-radiosurgery and other uses.
Its platforms include the CyberKnife System, which is used widely for stereotactic body radiation therapy (SBRT) and combines precision treatment delivery with real-time motion management.
The company earns revenue in two ways:
- Product sales of treatment systems, tracked through gross orders and backlog.
- Recurring service contracts across a global installed base of systems, which make up most of revenue and carry improving margins from pricing actions.
Accuray also holds an equity-method investment in a China joint venture.
It is executing a multi-year transformation plan aimed at lowering its cost structure and improving commercial performance. It is also deleveraging through a financing transaction with TCW that includes a debt-for-convertible-preferred exchange.
Its innovation strategy includes:
- a definitive agreement with RaySearch to accelerate online adaptive radiation therapy
- a collaboration with Samsung NeuroLogica on volumetric imaging for the CyberKnife System Updated
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with…
The top analyst upgrades, downgrades and other research calls from Wednesday include American Electric Power, Bank of America, Citigroup, Equinix, JD.com, Ralph Lauren and Sensata Technologies.
ThinkstockOnce again, the Wall Street conference calendar is heating up. Next week is the widely attended Jefferies Global Healthcare Conference in New York City. Following the success of last year’s conference, with…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Monday morning. Alliance Data Systems Corporation (NYSE: ADS) Cut to Market Perform at…
Active traders and day traders have many stocks to choose from this Wednesday morning. We are tracking news and moves in shares of Acuray Incorporated, Inc. (NASDAQ: ARAY), BSD Medical corporation (NASDAQ: BSDM), Cypress Bioscience…
Today’s BioHealth Business Daily is full of some of the names you might expect to see, but it also has some unusual names as well. We are seeing share price moves in…
These are this Tuesday’s top day trader and active trader alerts with more detailed price and volume data and analysis provided by links to each story at VSInvestor.com: Accuray Incorporated (NASDAQ: ARAY)…
These are some of the top pre-market analyst upgrades and positive calls we have seen on Wall Street this Friday morning: Accuray (ARAY) Raised to Buy at Piper Jaffray. AstraZeneca (AZN) Raised…
Cadence Design Systems (CDNS) posts bad numbers and gets downgrades. Falls to $9.90 from 52-week high of $24.90. Accuray (ARAY) The radiosurgery device maker reported disappointing fiscal second-quarter results. Trades off to…
Accuray Inc. (NASDAQ: ARAY) is being punished in after-hours trading. The company posted earnings at $0.04 EPS on revenues of $52 million. The problem is that First Call was at $0.09 EPS…
Accuray (ARAY) Radiosurgery company has quarterly loss. Down to $12.90 from 52-week high of $31.09. Home Solutions (HSOA) Problems with credit facility. Down to $2.85 from 52-week high of $8.24. Tarragon (TARR)…